Dysphagia and Dysarthria in Children with Neuromuscular Diseases, a Prevalence Study.
Dysphagia
children
dysarthria
neuromuscular diseases
prevalence
Journal
Journal of neuromuscular diseases
ISSN: 2214-3602
Titre abrégé: J Neuromuscul Dis
Pays: Netherlands
ID NLM: 101649948
Informations de publication
Date de publication:
2020
2020
Historique:
pubmed:
17
3
2020
medline:
9
3
2021
entrez:
17
3
2020
Statut:
ppublish
Résumé
Dysphagia and dysarthria are frequently described in pediatric neuromuscular diseases (pNMD). The consequences can be substantial: failure to thrive, malnutrition, aspiration pneumonia, or communication problems. Early detection and identification of risk factors and etiology support preventing complications and morbidity, including impact on quality of life. Information about the prevalence of dysphagia and dysarthria in pNMD is scarce. To describe the pooled prevalence of dysphagia and dysarthria in pNMD in the Netherlands. In addition, we describe the prevalence of dysphagia and dysarthria each, and the prevalence of chewing (oral) and swallowing problems per diagnostic group, based on their anatomic origin. Data were collected from 295 children (mean age 11;0 years, range 2;6-18;0) with pNMD in 12 hospitals and rehabilitation centers in the Netherlands. A speech language therapist established whether dysphagia and dysarthria were present or not. In almost all the 14 diagnostic groups of pNMD, dysphagia and dysarthria were present. Pooled overall prevalence of dysphagia and dysarthria was 47.2% and 31.5%, respectively. Of 114 children with dysphagia, 90.0% had chewing problems, 43.0% showed swallowing problems and 33.3% showed both chewing and swallowing problems. The overall pooled prevalence of dysphagia and dysarthria was high in the population of pNMD. It can be argued that periodic monitoring of dysphagia and dysarthria and early referral to a speech language therapist should be a necessity from the start of the diagnosis in the whole pNMD population.
Sections du résumé
BACKGROUND
BACKGROUND
Dysphagia and dysarthria are frequently described in pediatric neuromuscular diseases (pNMD). The consequences can be substantial: failure to thrive, malnutrition, aspiration pneumonia, or communication problems. Early detection and identification of risk factors and etiology support preventing complications and morbidity, including impact on quality of life. Information about the prevalence of dysphagia and dysarthria in pNMD is scarce.
OBJECTIVE
OBJECTIVE
To describe the pooled prevalence of dysphagia and dysarthria in pNMD in the Netherlands. In addition, we describe the prevalence of dysphagia and dysarthria each, and the prevalence of chewing (oral) and swallowing problems per diagnostic group, based on their anatomic origin.
METHODS
METHODS
Data were collected from 295 children (mean age 11;0 years, range 2;6-18;0) with pNMD in 12 hospitals and rehabilitation centers in the Netherlands. A speech language therapist established whether dysphagia and dysarthria were present or not.
RESULTS
RESULTS
In almost all the 14 diagnostic groups of pNMD, dysphagia and dysarthria were present. Pooled overall prevalence of dysphagia and dysarthria was 47.2% and 31.5%, respectively. Of 114 children with dysphagia, 90.0% had chewing problems, 43.0% showed swallowing problems and 33.3% showed both chewing and swallowing problems.
CONCLUSIONS
CONCLUSIONS
The overall pooled prevalence of dysphagia and dysarthria was high in the population of pNMD. It can be argued that periodic monitoring of dysphagia and dysarthria and early referral to a speech language therapist should be a necessity from the start of the diagnosis in the whole pNMD population.
Identifiants
pubmed: 32176651
pii: JND190436
doi: 10.3233/JND-190436
pmc: PMC7369072
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
287-295Références
Disabil Rehabil. 2014;36(15):1285-9
pubmed: 24151818
Dev Med Child Neurol. 2016 Jul;58(7):698-705
pubmed: 26510705
Arch Phys Med Rehabil. 1994 Nov;75(11):1175-81
pubmed: 7979925
Dev Med Child Neurol. 2017 Jun;59(6):591-596
pubmed: 27935021
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Folia Phoniatr Logop. 2017;69(4):143-153
pubmed: 29393211
Neurology. 2009 Nov 24;73(21):1787-91
pubmed: 19933981
Disabil Rehabil. 2019 Aug;41(16):1898-1905
pubmed: 29558834
Eur J Paediatr Neurol. 2006 Sep-Nov;10(5-6):231-6
pubmed: 17045498
Lancet Neurol. 2018 Mar;17(3):251-267
pubmed: 29395989
Dysphagia. 2010 Dec;25(4):277-83
pubmed: 19763689
Arch Dis Child. 1999 Jun;80(6):542-7
pubmed: 10332004
Eur J Paediatr Neurol. 2008 May;12(3):239-45
pubmed: 18055233
J Pediatr. 2012 Mar;160(3):447-451.e1
pubmed: 21924737
Int J Pediatr Otorhinolaryngol. 2007 Mar;71(3):403-7
pubmed: 17182111
J Neuromuscul Dis. 2015 Nov 20;2(4):357-369
pubmed: 27858755
Dev Med Child Neurol. 2007 Jan;49(1):18-22
pubmed: 17209971
J Child Neurol. 2014 May;29(5):646-53
pubmed: 24022110
Dev Med Child Neurol. 2003 Mar;45(3):183-8
pubmed: 12613775
J Child Neurol. 2011 Nov;26(11):1392-6
pubmed: 21596705
Arch Oral Biol. 2009 Jan;54(1):26-31
pubmed: 18805518
Clin Pediatr (Phila). 2009 Apr;48(3):247-51
pubmed: 19023104
Int J Lang Commun Disord. 2018 May;53(3):576-583
pubmed: 29327796
Geriatr Gerontol Int. 2013 Apr;13(2):372-7
pubmed: 22805745
Pediatrics. 2001 Dec;108(6):E106
pubmed: 11731633
Thorax. 2012 Jul;67 Suppl 1:i1-40
pubmed: 22730428
J Child Neurol. 2010 Dec;25(12):1559-81
pubmed: 21078917
J Neurol. 2013 May;260(5):1295-303
pubmed: 23263593
J Inherit Metab Dis. 2012 May;35(3):505-11
pubmed: 22008944
J Child Neurol. 2014 Jul;29(7):983-6
pubmed: 23611887
Dysphagia. 2009 Sep;24(3):322-32
pubmed: 19259730
J Pediatr Rehabil Med. 2020;13(1):17-23
pubmed: 32176663